Erika Meaddough

Title: Innovations by Erika Meaddough

Introduction

Erika Meaddough is an accomplished inventor based in Gilroy, California. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer treatment. With a total of two patents to her name, her work has the potential to impact the lives of many patients suffering from various forms of cancer.

Latest Patents

One of Erika's latest patents involves antibodies that bind to the extracellular domain of the Tyrosine-protein kinase transmembrane receptor Matriptase. This invention provides not only the antibodies but also nucleic acid molecules encoding them, expression vectors, and host cells for their production. These antibodies may be utilized in the treatment of several cancers, including gastric, colorectal, prostate, breast, ovarian, lung, esophageal, head and neck, pancreatic cancers, lymphoma, and skin cancer.

Another significant patent focuses on fully human antibodies specific to CADM1. This disclosure includes isolated monoclonal antibodies, particularly engineered antibodies that exhibit increased binding to Fc receptors and enhanced potency for antibody-dependent cellular cytotoxicity (ADCC) or immunoconjugates. The patent also covers nucleic acid molecules encoding CADM1 antibodies, expression vectors, host cells, and methods for their expression. Furthermore, it provides methods for detecting CADM1 and treating various cancers, including lung and pancreatic cancer.

Career Highlights

Erika has worked with notable companies in the biotechnology sector, including Oxford Biotherapeutics Ltd and Medarex Inc. Her experience in these organizations has contributed to her expertise in developing innovative therapeutic solutions.

Collaborations

Erika has collaborated with several professionals in her field, including Jonathan Alexander Terrett and Chetana Rao-Naik. These collaborations have likely enriched her research and development efforts.

Conclusion

Erika Meaddough's contributions to the field of biotechnology through her innovative patents demonstrate her commitment to advancing cancer treatment. Her work continues to pave the way for new therapeutic options that could benefit countless patients.